InsiderTrades.com logo
Bill Gates’s Next Big AI Bet: Stargate
From Brownstone Research   |   Ad
In February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of my favorite stocks. Shares have jumped by more than 20,000% since then.
I believe we are about to do it again with this new AI project called Stargate

AMRX Insider Trading

Insider Ownership Percentage: 26.56%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $375,886.77

Amneal Pharmaceuticals Insider Trading History Chart

This chart shows the insider buying and selling history at Amneal Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Amneal Pharmaceuticals Share Price & Price History

Current Price: $8.32
Price Change: ▼ Price Decrease of -0.09 (-1.07%)
As of 11/21/2024 06:38 PM ET

This chart shows the closing price history over time for AMRX up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
Financial Prophecy
From Porter & Company   |   Ad
The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold $3 billion of Amazon… it’s why Nvidia’s CEO just sold $713 million... and it’s why Zuckerberg just sold $1.3 billion in Meta stock. The financial establishment doesn’t want you to know about this… but a controversial new documentary just pulled back the curtain and exposed what’s really going on. It’s called The Final Frontier.
Including the name of the #1 company to buy.

Amneal Pharmaceuticals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/15/2024Jason B DalySVPSell43,657$8.61$375,886.7713,665View SEC Filing Icon  
8/11/2023Andrew S. BoyerEVPSell29,302$4.13$121,017.26244,739View SEC Filing Icon  
12/12/2022Tpg Gp A, LlcMajor ShareholderSell3,884,600$2.34$9,089,964.0012,328,767View SEC Filing Icon  
12/17/2021Gautam PatelDirectorBuy50,000$4.21$210,500.00View SEC Filing Icon  
12/15/2021Chirag K. PatelCEOBuy100,000$4.13$413,000.00View SEC Filing Icon  
12/15/2021Nikita ShahEVPSell2,000$3.95$7,900.00View SEC Filing Icon  
12/2/2021Joseph TodiscoEVPSell1,500$4.10$6,150.00View SEC Filing Icon  
See Full Table
Urgent: This election is rigged
From Porter & Company   |   Ad
If you missed it, my emergency election broadcast is now available - but will be removed soon
Click here to watch it now.

SEC Filings (Institutional Ownership Changes) for Amneal Pharmaceuticals (NASDAQ:AMRX)

31.82% of Amneal Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at AMRX by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Amneal Pharmaceuticals Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/16/2024Geode Capital Management LLC3,786,671$31.51M0.0%+11.1%1.223%Search for SEC Filing on Google Icon
11/15/2024Barclays PLC296,384$2.47M0.0%+134.1%0.096%Search for SEC Filing on Google Icon
11/15/2024Y Intercept Hong Kong Ltd37,425$0.31M0.0%N/A0.012%Search for SEC Filing on Google Icon
11/15/2024XTX Topco Ltd22,210$0.19M0.0%-31.2%0.007%Search for SEC Filing on Google Icon
11/15/2024Jane Street Group LLC81,883$0.68M0.0%-48.0%0.026%Search for SEC Filing on Google Icon
11/15/2024Wellington Management Group LLP82,596$0.69M0.0%N/A0.027%Search for SEC Filing on Google Icon
11/15/2024State Street Corp3,514,721$29.24M0.0%+3.8%1.135%Search for SEC Filing on Google Icon
11/15/2024Quadrature Capital Ltd20,336$0.17M0.0%N/A0.007%Search for SEC Filing on Google Icon
11/15/2024Polar Asset Management Partners Inc.393,000$3.27M0.1%+122.5%0.127%Search for SEC Filing on Google Icon
11/15/2024Jacobs Levy Equity Management Inc.97,379$0.81M0.0%-66.1%0.031%Search for SEC Filing on Google Icon
11/14/2024Bellevue Group AG76,414$0.64M0.0%+21.8%0.025%Search for SEC Filing on Google Icon
11/14/2024Verition Fund Management LLC46,344$0.39M0.0%-10.9%0.015%Search for SEC Filing on Google Icon
11/14/2024Walleye Capital LLC131,667$1.10M0.0%N/A0.043%Search for SEC Filing on Google Icon
11/14/2024UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC218,554$1.82M0.0%-17.4%0.071%Search for SEC Filing on Google Icon
11/13/2024BNP Paribas Financial Markets54,398$0.45M0.0%-88.1%0.018%Search for SEC Filing on Google Icon
11/13/2024FMR LLC203,510$1.69M0.0%+25.9%0.066%Search for SEC Filing on Google Icon
11/13/2024Quantbot Technologies LP111,181$0.93M0.0%+274.8%0.036%Search for SEC Filing on Google Icon
11/13/2024The Manufacturers Life Insurance Company 89,425$0.74M0.0%-5.1%0.029%Search for SEC Filing on Google Icon
11/12/2024Algert Global LLC448,206$3.73M0.1%-1.0%0.145%Search for SEC Filing on Google Icon
11/12/2024Charles Schwab Investment Management Inc.1,404,883$11.69M0.0%+16.9%0.454%Search for SEC Filing on Google Icon
11/12/2024Massachusetts Financial Services Co. MA190,662$1.59M0.0%-2.4%0.062%Search for SEC Filing on Google Icon
11/9/2024Intech Investment Management LLC36,847$0.31M0.0%N/A0.012%Search for SEC Filing on Google Icon
11/8/2024Connor Clark & Lunn Investment Management Ltd.548,975$4.57M0.0%-1.6%0.177%Search for SEC Filing on Google Icon
11/8/2024Segall Bryant & Hamill LLC489,162$4.07M0.1%+1.6%0.158%Search for SEC Filing on Google Icon
11/8/2024Phocas Financial Corp.1,015,190$8.45M0.0%-5.9%0.328%Search for SEC Filing on Google Icon
11/7/2024Quest Partners LLC10,086$84K0.0%N/A0.003%Search for SEC Filing on Google Icon
11/6/2024Gladius Capital Management LP4,390$37K0.0%N/A0.001%Search for SEC Filing on Google Icon
11/5/2024Victory Capital Management Inc.99,215$0.83M0.0%+58.7%0.032%Search for SEC Filing on Google Icon
11/5/2024Aigen Investment Management LP25,591$0.21M0.0%N/A0.008%Search for SEC Filing on Google Icon
11/5/2024GSA Capital Partners LLP54,350$0.45M0.0%-64.9%0.018%Search for SEC Filing on Google Icon
11/4/2024Versor Investments LP40,200$0.33M0.1%+191.3%0.013%Search for SEC Filing on Google Icon
11/4/2024Chartwell Investment Partners LLC82,410$0.69M0.0%+21.3%0.027%Search for SEC Filing on Google Icon
10/31/2024Principal Financial Group Inc.88,622$0.74M0.0%-5.3%0.029%Search for SEC Filing on Google Icon
10/24/2024Nisa Investment Advisors LLC7,069$59K0.0%-96.9%0.002%Search for SEC Filing on Google Icon
10/23/2024Assenagon Asset Management S.A.1,204,994$10.03M0.0%+114.1%0.390%Search for SEC Filing on Google Icon
10/22/2024Private Advisor Group LLC26,992$0.23M0.0%-48.3%0.009%Search for SEC Filing on Google Icon
10/19/2024Allspring Global Investments Holdings LLC38,799$0.32M0.0%-30.7%0.013%Search for SEC Filing on Google Icon
10/11/2024Creative Planning16,555$0.14M0.0%-13.1%0.005%Search for SEC Filing on Google Icon
10/10/2024Ritholtz Wealth Management135,551$1.13M0.0%-15.1%0.044%Search for SEC Filing on Google Icon
10/3/2024SG Americas Securities LLC63,844$0.53M0.0%N/A0.021%Search for SEC Filing on Google Icon
8/20/2024Nantahala Capital Management LLC2,669,943$16.95M1.0%+1.9%0.865%Search for SEC Filing on Google Icon
8/16/2024Algert Global LLC452,724$2.88M0.1%+11.5%0.147%Search for SEC Filing on Google Icon
8/15/2024The Manufacturers Life Insurance Company94,195$0.60M0.0%+32.0%0.031%Search for SEC Filing on Google Icon
8/15/2024AQR Capital Management LLC435,082$2.76M0.0%-42.5%0.141%Search for SEC Filing on Google Icon
8/14/2024Squarepoint Ops LLC111,274$0.71M0.0%N/A0.036%Search for SEC Filing on Google Icon
8/14/2024BlackBarn Capital Partners LP2,000,000$12.70M1.1%+41.5%0.648%Search for SEC Filing on Google Icon
8/14/2024Xponance Inc.10,214$65K0.0%N/A0.003%Search for SEC Filing on Google Icon
8/14/2024ProShare Advisors LLC16,327$0.10M0.0%-25.5%0.005%Search for SEC Filing on Google Icon
8/14/2024Profund Advisors LLC22,522$0.14M0.0%+8.1%0.007%Search for SEC Filing on Google Icon
8/13/2024Rubric Capital Management LP10,721,778$68.08M1.8%+12.4%3.474%Search for SEC Filing on Google Icon
8/13/2024Thrivent Financial for Lutherans94,839$0.60M0.0%-4.1%0.031%Search for SEC Filing on Google Icon
8/13/2024Sei Investments Co.127,100$0.81M0.0%+257.9%0.041%Search for SEC Filing on Google Icon
8/12/2024XTX Topco Ltd32,272$0.21M0.0%-6.2%0.010%Search for SEC Filing on Google Icon
8/12/2024Hsbc Holdings PLC43,841$0.28M0.0%-85.0%0.014%Search for SEC Filing on Google Icon
8/9/2024Renaissance Technologies LLC682,700$4.34M0.0%+28.2%0.221%Search for SEC Filing on Google Icon
8/9/2024Dimensional Fund Advisors LP4,283,928$27.21M0.0%+17.6%1.388%Search for SEC Filing on Google Icon
8/9/2024Massachusetts Financial Services Co. MA195,279$1.24M0.0%-12.0%0.063%Search for SEC Filing on Google Icon
8/8/2024Federated Hermes Inc.265,534$1.69M0.0%-2.2%0.086%Search for SEC Filing on Google Icon
8/8/2024DekaBank Deutsche Girozentrale6,655$42K0.0%N/A0.002%Search for SEC Filing on Google Icon
8/8/2024American Century Companies Inc.33,314$0.21M0.0%-85.3%0.011%Search for SEC Filing on Google Icon
8/6/2024LSV Asset Management1,057,300$6.71M0.0%-0.8%0.343%Search for SEC Filing on Google Icon
8/6/2024Acadian Asset Management LLC811,853$5.15M0.0%+701.8%0.263%Search for SEC Filing on Google Icon
8/5/2024Victory Capital Management Inc.62,515$0.40M0.0%-59.2%0.020%Search for SEC Filing on Google Icon
8/2/2024Jackson Creek Investment Advisors LLC161,760$1.03M0.4%N/A0.052%Search for SEC Filing on Google Icon
8/1/2024Rhumbline Advisers233,217$1.48M0.0%+14.9%0.076%Search for SEC Filing on Google Icon
8/1/2024Versor Investments LP13,800$88K0.0%-80.6%0.004%Search for SEC Filing on Google Icon
8/1/2024Convergence Investment Partners LLC143,215$0.91M0.3%N/A0.046%Search for SEC Filing on Google Icon
8/1/2024Hussman Strategic Advisors Inc.147,000$0.93M0.3%N/A0.048%Search for SEC Filing on Google Icon
8/1/2024Ritholtz Wealth Management159,710$1.01M0.0%+19.3%0.052%Search for SEC Filing on Google Icon
7/31/2024nVerses Capital LLC9,800$62K0.0%N/A0.003%Search for SEC Filing on Google Icon
7/31/2024Rothschild Investment LLC4,060$26K0.0%N/A0.001%Search for SEC Filing on Google Icon
7/29/2024Principal Financial Group Inc.93,566$0.59M0.0%-15.0%0.030%Search for SEC Filing on Google Icon
7/29/2024Zurcher Kantonalbank Zurich Cantonalbank34,952$0.22M0.0%+13.3%0.011%Search for SEC Filing on Google Icon
7/26/2024Allspring Global Investments Holdings LLC55,951$0.36M0.0%-56.7%0.018%Search for SEC Filing on Google Icon
7/26/2024Bank of New York Mellon Corp751,403$4.77M0.0%+20.7%0.243%Search for SEC Filing on Google Icon
7/23/2024Hennessy Advisors Inc.1,388,600$8.82M0.3%N/A0.450%Search for SEC Filing on Google Icon
7/20/2024Nisa Investment Advisors LLC228,917$1.45M0.0%+3,279.8%0.074%Search for SEC Filing on Google Icon
7/18/2024Assenagon Asset Management S.A.562,929$3.58M0.0%+3.0%0.182%Search for SEC Filing on Google Icon
7/12/2024Sanders Morris Harris LLC567,196$3.60M0.6%+127.2%0.184%Search for SEC Filing on Google Icon
5/20/2024EMC Capital Management31,090$0.19M0.1%-23.4%0.010%Search for SEC Filing on Google Icon
5/16/2024California State Teachers Retirement System122,504$0.74M0.0%+5.4%0.040%Search for SEC Filing on Google Icon
5/16/2024Virtus Investment Advisers Inc.34,510$0.21M0.1%-42.2%0.011%Search for SEC Filing on Google Icon
5/16/2024Jacobs Levy Equity Management Inc.345,248$2.09M0.0%-13.7%0.112%Search for SEC Filing on Google Icon
5/16/2024Bayesian Capital Management LP10,754$65K0.0%N/A0.004%Search for SEC Filing on Google Icon
5/16/2024Caxton Associates LP91,481$0.55M0.0%+9.7%0.030%Search for SEC Filing on Google Icon
5/15/2024Bellevue Group AG45,387$0.28M0.0%+78.2%0.015%Search for SEC Filing on Google Icon
5/15/2024Price T Rowe Associates Inc. MD81,264$0.49M0.0%+6.8%0.026%Search for SEC Filing on Google Icon
5/14/2024CANADA LIFE ASSURANCE Co36,106$0.22M0.0%+417.8%0.012%Search for SEC Filing on Google Icon
5/13/2024Atlanta Consulting Group Advisors LLC10,000$61K0.0%N/A0.003%Search for SEC Filing on Google Icon
5/13/2024O Shaughnessy Asset Management LLC189,285$1.15M0.0%+26.5%0.062%Search for SEC Filing on Google Icon
5/11/2024Hillsdale Investment Management Inc.699,719$4.24M0.3%+19.7%0.228%Search for SEC Filing on Google Icon
5/10/2024Acadian Asset Management LLC101,255$0.61M0.0%+12.7%0.033%Search for SEC Filing on Google Icon
5/10/2024Vanguard Group Inc.13,728,233$83.19M0.0%+0.6%4.472%Search for SEC Filing on Google Icon
5/8/2024ProShare Advisors LLC21,902$0.13M0.0%+8.6%0.007%Search for SEC Filing on Google Icon
5/8/2024Russell Investments Group Ltd.175,685$1.07M0.0%-72.8%0.057%Search for SEC Filing on Google Icon
5/7/2024Susquehanna Portfolio Strategies LLC64,584$0.39M0.0%-4.8%0.021%Search for SEC Filing on Google Icon
5/7/2024Swiss National Bank242,100$1.47M0.0%+13.8%0.079%Search for SEC Filing on Google Icon
5/7/2024SG Americas Securities LLC20,112$0.12M0.0%+18.8%0.007%Search for SEC Filing on Google Icon
5/6/2024LSV Asset Management1,065,600$6.46M0.0%-2.2%0.347%Search for SEC Filing on Google Icon
5/3/2024GSA Capital Partners LLP182,962$1.11M0.1%N/A0.060%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Amneal Pharmaceuticals logo
Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, manufactures, markets, and distributes generics, injectables, biosimilars, and specialty branded pharmaceutical products worldwide. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment offers immediate and extended release oral solid, powder, liquid, sterile injectable, nasal spray, inhalation and respiratory, biosimilar, ophthalmic, film, transdermal patch, and topical products. The Specialty segment develops, promotes, sells, and distributes pharmaceutical products with focus on central nervous system disorders, including Parkinson's disease, and endocrine disorders. This segment also provides Rytary, an oral capsule formulation of carbidopa-levodopa to treat Parkinson's disease, post-encephalitic parkinsonism, and parkinsonism; Unithroid for the treatment of hypothyroidism; and IPX203, a pipeline product for Parkinson's disease. The AvKARE segment offers pharmaceuticals, medical and surgical products, and services primarily to governmental agencies, the Department of Defense, and the Department of Veterans Affairs. This segment also distributes bottle and unit dose pharmaceuticals under the AvKARE and AvPAK names; and packages and distributes pharmaceuticals and vitamins to its retail and institutional customers. It sells its products through wholesalers, distributors, hospitals, chain pharmacies, and individual pharmacies. The company was formerly known as Atlas Holdings, Inc. and changed its name to Amneal Pharmaceuticals, Inc. in 2018. Amneal Pharmaceuticals, Inc. was founded in 2002 and is headquartered in Bridgewater, New Jersey.
Read More on Amneal Pharmaceuticals

Today's Range

Now: $8.32
Low: $8.28
High: $8.47

50 Day Range

MA: $8.58
Low: $8.19
High: $9.25

52 Week Range

Now: $8.32
Low: $4.16
High: $9.48

Volume

796,877 shs

Average Volume

1,399,818 shs

Market Capitalization

$2.58 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.17

Who are the company insiders with the largest holdings of Amneal Pharmaceuticals?

Amneal Pharmaceuticals' top insider shareholders include:
  1. Tpg Gp A, Llc (Major Shareholder)
  2. Andrew S Boyer (EVP)
  3. Jason B Daly (SVP)
Learn More about top insider investors at Amneal Pharmaceuticals.

Who are the major institutional investors of Amneal Pharmaceuticals?

Amneal Pharmaceuticals' top institutional shareholders include:
  1. Geode Capital Management LLC — 1.22%
  2. State Street Corp — 1.14%
  3. Charles Schwab Investment Management Inc. — 0.45%
  4. Assenagon Asset Management S.A. — 0.39%
  5. Phocas Financial Corp. — 0.33%
  6. Connor Clark & Lunn Investment Management Ltd. — 0.18%
Learn More about top institutional investors of Amneal Pharmaceuticals stock.

Which major investors are selling Amneal Pharmaceuticals stock?

During the previous quarter, AMRX stock was sold by these institutional investors:
  1. BNP Paribas Financial Markets
  2. Nisa Investment Advisors LLC
  3. Jacobs Levy Equity Management Inc.
  4. GSA Capital Partners LLP
  5. Jane Street Group LLC
  6. Phocas Financial Corp.
  7. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
  8. Private Advisor Group LLC

Which major investors are buying Amneal Pharmaceuticals stock?

In the previous quarter, AMRX stock was purchased by institutional investors including:
  1. Assenagon Asset Management S.A.
  2. Geode Capital Management LLC
  3. Polar Asset Management Partners Inc.
  4. Charles Schwab Investment Management Inc.
  5. Barclays PLC
  6. Walleye Capital LLC
  7. State Street Corp
  8. Wellington Management Group LLP
Watch this before it gets removed
From Porter & Company   |   Ad
If you missed it, my emergency election broadcast is now available - but will be removed soon
Click here to watch it now.